摘要
目的分析米非司酮治疗部分胎盘植入与胎盘粘连的临床效果。方法我院于2017年9月至2018年9月接收56例部分胎盘植入与胎盘粘连患者。采用随机数表法分为对照组(n=28)与观察组(n=28)。对照组患者采用缩宫素治疗,观察组患者应用米非司酮治疗。对照分析两组患者治疗效果。结果观察组患者产后12、24、72 h出血量均少于对照组,胎盘排出时间、血β-HCG恢复时间及B超胎盘恢复时间均短于对照组,产后生活质量评分高于对照组,且并发症发生率低于对照组,组间差异均有显著性(P <0.05)。结论应用米非司酮治疗部分胎盘植入与胎盘粘连效果更显著,可减少出血量,有助于患者产后恢复,并提高患者生活质量,预防并发症的产生,临床应用价值较高。
Objective To analyze the clinical effect of mifepristone in the treatment of some placental implantation and placental adhesions. Methods From September 2017 to September 2018, 56 patients with partial placenta implantation and placental adhesions were accepted in our hospital. Using random number table method, they were divided into control group and observation group, with 28 cases in both groups. Patients in the control group were treated with oxytocin, and patients in the observation group were treated with mifepristone. The treatment effect of the two groups of patients was compared. Results The blood loss at 12, 24, and 72 hours postpartum of the observation group was less than that of the control group. The placental discharge time, blood β-HCG recovery time and B-ultrasonic placental recovery time of the observation group were shorter than those of the control group, and the postpartum quality of life score was higher than that of the control group. The incidence of complications of the observation group was lower than that of the control group, and the differences between the groups were significant(P<0.05). Conclusion The application of mifepristone to treat some placental implantation and placental adhesions is more effective, can reduce bleeding, help patients recover after delivery, improve the quality of life of patients, prevent complications, and has high clinical application value.
作者
陶然
TAO Ran(Women and Infants Hospital of Jinzhou City,Jinzhou 121000,China)
出处
《中国医药指南》
2021年第2期47-48,共2页
Guide of China Medicine
关键词
胎盘植入
胎盘粘连
米非司酮
Placental implantation
The placenta adhesion
Mifepristone
